Amalgent Therapeutics
Greenville
About Amalgent Therapeutics
Amalgent Therapeutics is developing combination drugs that dramatically reduce the doses required for effective analgesia. The company was founded in 2020 and is headquartered in Chapel Hill, North Carolina, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $450.0K
- Last round: Debt Financing (Feb 2023)
- Website: amalgent.com
- Phone: 919-225-9022
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/amalgent-therapeutics-33022 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.